List of Tables
Table 1. Global Opioid-Induced Constipation Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Opioid-Induced Constipation Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Opioid-Induced Constipation Market Competitive Situation by Manufacturers in 2022
Table 4. Global Opioid-Induced Constipation Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Opioid-Induced Constipation Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Opioid-Induced Constipation Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Opioid-Induced Constipation Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Opioid-Induced Constipation Average Price (USD/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Opioid-Induced Constipation, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Opioid-Induced Constipation, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Opioid-Induced Constipation, Product Type & Application
Table 12. Global Key Manufacturers of Opioid-Induced Constipation, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Opioid-Induced Constipation by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Opioid-Induced Constipation as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Opioid-Induced Constipation Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Opioid-Induced Constipation Sales by Region (2018-2023) & (K Units)
Table 18. Global Opioid-Induced Constipation Sales Market Share by Region (2018-2023)
Table 19. Global Opioid-Induced Constipation Sales by Region (2024-2029) & (K Units)
Table 20. Global Opioid-Induced Constipation Sales Market Share by Region (2024-2029)
Table 21. Global Opioid-Induced Constipation Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Opioid-Induced Constipation Revenue Market Share by Region (2018-2023)
Table 23. Global Opioid-Induced Constipation Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Opioid-Induced Constipation Revenue Market Share by Region (2024-2029)
Table 25. North America Opioid-Induced Constipation Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Opioid-Induced Constipation Sales by Country (2018-2023) & (K Units)
Table 27. North America Opioid-Induced Constipation Sales by Country (2024-2029) & (K Units)
Table 28. North America Opioid-Induced Constipation Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Opioid-Induced Constipation Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Opioid-Induced Constipation Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Opioid-Induced Constipation Sales by Country (2018-2023) & (K Units)
Table 32. Europe Opioid-Induced Constipation Sales by Country (2024-2029) & (K Units)
Table 33. Europe Opioid-Induced Constipation Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Opioid-Induced Constipation Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Opioid-Induced Constipation Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Opioid-Induced Constipation Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Opioid-Induced Constipation Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Opioid-Induced Constipation Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Opioid-Induced Constipation Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Opioid-Induced Constipation Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Opioid-Induced Constipation Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Opioid-Induced Constipation Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Opioid-Induced Constipation Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Opioid-Induced Constipation Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Opioid-Induced Constipation Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Opioid-Induced Constipation Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Opioid-Induced Constipation Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Opioid-Induced Constipation Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Opioid-Induced Constipation Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Opioid-Induced Constipation Sales (K Units) by Type (2018-2023)
Table 51. Global Opioid-Induced Constipation Sales (K Units) by Type (2024-2029)
Table 52. Global Opioid-Induced Constipation Sales Market Share by Type (2018-2023)
Table 53. Global Opioid-Induced Constipation Sales Market Share by Type (2024-2029)
Table 54. Global Opioid-Induced Constipation Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Opioid-Induced Constipation Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Opioid-Induced Constipation Revenue Market Share by Type (2018-2023)
Table 57. Global Opioid-Induced Constipation Revenue Market Share by Type (2024-2029)
Table 58. Global Opioid-Induced Constipation Price (USD/Unit) by Type (2018-2023)
Table 59. Global Opioid-Induced Constipation Price (USD/Unit) by Type (2024-2029)
Table 60. Global Opioid-Induced Constipation Sales (K Units) by Application (2018-2023)
Table 61. Global Opioid-Induced Constipation Sales (K Units) by Application (2024-2029)
Table 62. Global Opioid-Induced Constipation Sales Market Share by Application (2018-2023)
Table 63. Global Opioid-Induced Constipation Sales Market Share by Application (2024-2029)
Table 64. Global Opioid-Induced Constipation Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Opioid-Induced Constipation Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Opioid-Induced Constipation Revenue Market Share by Application (2018-2023)
Table 67. Global Opioid-Induced Constipation Revenue Market Share by Application (2024-2029)
Table 68. Global Opioid-Induced Constipation Price (USD/Unit) by Application (2018-2023)
Table 69. Global Opioid-Induced Constipation Price (USD/Unit) by Application (2024-2029)
Table 70. Takeda Pharmaceuticals Corporation Information
Table 71. Takeda Pharmaceuticals Description and Business Overview
Table 72. Takeda Pharmaceuticals Opioid-Induced Constipation Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 73. Takeda Pharmaceuticals Opioid-Induced Constipation Product
Table 74. Takeda Pharmaceuticals Recent Developments/Updates
Table 75. Bayer Corporation Information
Table 76. Bayer Description and Business Overview
Table 77. Bayer Opioid-Induced Constipation Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 78. Bayer Opioid-Induced Constipation Product
Table 79. Bayer Recent Developments/Updates
Table 80. Sanofi Corporation Information
Table 81. Sanofi Description and Business Overview
Table 82. Sanofi Opioid-Induced Constipation Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 83. Sanofi Opioid-Induced Constipation Product
Table 84. Sanofi Recent Developments/Updates
Table 85. Mallinckrodt Corporation Information
Table 86. Mallinckrodt Description and Business Overview
Table 87. Mallinckrodt Opioid-Induced Constipation Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 88. Mallinckrodt Opioid-Induced Constipation Product
Table 89. Mallinckrodt Recent Developments/Updates
Table 90. Salix (Bausch Health) Corporation Information
Table 91. Salix (Bausch Health) Description and Business Overview
Table 92. Salix (Bausch Health) Opioid-Induced Constipation Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 93. Salix (Bausch Health) Opioid-Induced Constipation Product
Table 94. Salix (Bausch Health) Recent Developments/Updates
Table 95. AstraZeneca Corporation Information
Table 96. AstraZeneca Description and Business Overview
Table 97. AstraZeneca Opioid-Induced Constipation Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 98. AstraZeneca Opioid-Induced Constipation Product
Table 99. AstraZeneca Recent Developments/Updates
Table 100. Progenics Pharmaceuticals Corporation Information
Table 101. Progenics Pharmaceuticals Description and Business Overview
Table 102. Progenics Pharmaceuticals Opioid-Induced Constipation Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 103. Progenics Pharmaceuticals Opioid-Induced Constipation Product
Table 104. Progenics Pharmaceuticals Recent Developments/Updates
Table 105. Purdue Pharm Corporation Information
Table 106. Purdue Pharm Description and Business Overview
Table 107. Purdue Pharm Opioid-Induced Constipation Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 108. Purdue Pharm Opioid-Induced Constipation Product
Table 109. Purdue Pharm Recent Developments/Updates
Table 110. Nektar Therapeutics Corporation Information
Table 111. Nektar Therapeutics Description and Business Overview
Table 112. Nektar Therapeutics Opioid-Induced Constipation Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 113. Nektar Therapeutics Opioid-Induced Constipation Product
Table 114. Nektar Therapeutics Recent Developments/Updates
Table 115. Daiichi Sankyo Corporation Information
Table 116. Daiichi Sankyo Description and Business Overview
Table 117. Daiichi Sankyo Opioid-Induced Constipation Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 118. Daiichi Sankyo Opioid-Induced Constipation Product
Table 119. Daiichi Sankyo Recent Developments/Updates
Table 120. Prestige Corporation Information
Table 121. Prestige Description and Business Overview
Table 122. Prestige Opioid-Induced Constipation Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 123. Prestige Opioid-Induced Constipation Product
Table 124. Prestige Recent Developments/Updates
Table 125. GSK Corporation Information
Table 126. GSK Description and Business Overview
Table 127. GSK Opioid-Induced Constipation Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 128. GSK Opioid-Induced Constipation Product
Table 129. GSK Recent Developments/Updates
Table 130. Shionogi Corporation Information
Table 131. Shionogi Description and Business Overview
Table 132. Shionogi Opioid-Induced Constipation Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 133. Shionogi Opioid-Induced Constipation Product
Table 134. Shionogi Recent Developments/Updates
Table 135. Key Raw Materials Lists
Table 136. Raw Materials Key Suppliers Lists
Table 137. Opioid-Induced Constipation Distributors List
Table 138. Opioid-Induced Constipation Customers List
Table 139. Opioid-Induced Constipation Market Trends
Table 140. Opioid-Induced Constipation Market Drivers
Table 141. Opioid-Induced Constipation Market Challenges
Table 142. Opioid-Induced Constipation Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Opioid-Induced Constipation
Figure 2. Global Opioid-Induced Constipation Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Opioid-Induced Constipation Market Share by Type in 2022 & 2029
Figure 4. Methylnaltrexone Bromide Product Picture
Figure 5. Lubiprostone Product Picture
Figure 6. Naloxegol Product Picture
Figure 7. Others Product Picture
Figure 8. Global Opioid-Induced Constipation Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 9. Global Opioid-Induced Constipation Market Share by Application in 2022 & 2029
Figure 10. Hospital
Figure 11. Pharmacy
Figure 12. Other
Figure 13. Global Opioid-Induced Constipation Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Opioid-Induced Constipation Market Size (2018-2029) & (US$ Million)
Figure 15. Global Opioid-Induced Constipation Sales (2018-2029) & (K Units)
Figure 16. Global Opioid-Induced Constipation Average Price (USD/Unit) & (2018-2029)
Figure 17. Opioid-Induced Constipation Report Years Considered
Figure 18. Opioid-Induced Constipation Sales Share by Manufacturers in 2022
Figure 19. Global Opioid-Induced Constipation Revenue Share by Manufacturers in 2022
Figure 20. The Global 5 and 10 Largest Opioid-Induced Constipation Players: Market Share by Revenue in 2022
Figure 21. Opioid-Induced Constipation Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 22. Global Opioid-Induced Constipation Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 23. North America Opioid-Induced Constipation Sales Market Share by Country (2018-2029)
Figure 24. North America Opioid-Induced Constipation Revenue Market Share by Country (2018-2029)
Figure 25. U.S. Opioid-Induced Constipation Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 26. Canada Opioid-Induced Constipation Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. Europe Opioid-Induced Constipation Sales Market Share by Country (2018-2029)
Figure 28. Europe Opioid-Induced Constipation Revenue Market Share by Country (2018-2029)
Figure 29. Germany Opioid-Induced Constipation Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. France Opioid-Induced Constipation Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. U.K. Opioid-Induced Constipation Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Italy Opioid-Induced Constipation Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Russia Opioid-Induced Constipation Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Asia Pacific Opioid-Induced Constipation Sales Market Share by Region (2018-2029)
Figure 35. Asia Pacific Opioid-Induced Constipation Revenue Market Share by Region (2018-2029)
Figure 36. China Opioid-Induced Constipation Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. Japan Opioid-Induced Constipation Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. South Korea Opioid-Induced Constipation Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. India Opioid-Induced Constipation Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Australia Opioid-Induced Constipation Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Taiwan Opioid-Induced Constipation Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Indonesia Opioid-Induced Constipation Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Thailand Opioid-Induced Constipation Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Malaysia Opioid-Induced Constipation Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Philippines Opioid-Induced Constipation Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Latin America Opioid-Induced Constipation Sales Market Share by Country (2018-2029)
Figure 47. Latin America Opioid-Induced Constipation Revenue Market Share by Country (2018-2029)
Figure 48. Mexico Opioid-Induced Constipation Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Brazil Opioid-Induced Constipation Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Argentina Opioid-Induced Constipation Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Middle East & Africa Opioid-Induced Constipation Sales Market Share by Country (2018-2029)
Figure 52. Middle East & Africa Opioid-Induced Constipation Revenue Market Share by Country (2018-2029)
Figure 53. Turkey Opioid-Induced Constipation Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. Saudi Arabia Opioid-Induced Constipation Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 55. U.A.E Opioid-Induced Constipation Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 56. Global Sales Market Share of Opioid-Induced Constipation by Type (2018-2029)
Figure 57. Global Revenue Market Share of Opioid-Induced Constipation by Type (2018-2029)
Figure 58. Global Opioid-Induced Constipation Price (USD/Unit) by Type (2018-2029)
Figure 59. Global Sales Market Share of Opioid-Induced Constipation by Application (2018-2029)
Figure 60. Global Revenue Market Share of Opioid-Induced Constipation by Application (2018-2029)
Figure 61. Global Opioid-Induced Constipation Price (USD/Unit) by Application (2018-2029)
Figure 62. Opioid-Induced Constipation Value Chain
Figure 63. Opioid-Induced Constipation Production Process
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Distributors Profiles
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed